Analyst Rating Changes — Upgrades, Downgrades & Price Targets

46577 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Rating Changes

When	Stock	Change	Firm	Analyst	Rating	Price Target
Sep 10 00:58 UTC	FCX Freeport-McMoRan	◎ Target	Sanford C. Bernstein	Bob Brackett ★★★★★ #296	Market Perform	$50.00→ $47.00-6.0%
Sep 10 00:58 UTC	FCH Funding Circle	◎ Target	Canaccord Genuity Group	firm only	Buy	GBX 300→ GBX 308+2.7%
Sep 10 00:58 UTC	EXE Expand Energy	◎ Target	Raymond James Financial	John Freeman ★★★★☆ #860	Strong-Buy	$145.00→ $147.00+1.4%
Sep 10 00:58 UTC	EVMN Evommune	◎ Target	Leerink Partners	Thomas Smith ★★★★☆ #529	Outperform	$28.00→ $22.00-21.4%
Sep 10 00:58 UTC	EVMN Evommune	◎ Target	Royal Bank Of Canada	Brian Abrahams ★★☆☆☆ #2565	Outperform	$29.00→ $21.00-27.6%
Sep 10 00:58 UTC	ETOR eToro Group	◎ Target	The Goldman Sachs Group	James Yaro ★★☆☆☆ #2427	Neutral	$32.00→ $36.00+12.5%
Sep 10 00:58 UTC	EPR EPR Properties	◎ Target	JPMorgan Chase & Co.	Anthony Paolone ★★★☆☆ #1018	Overweight	$62.00→ $65.00+4.8%
Sep 10 00:58 UTC	EFSI Eagle Financial Services	◎ Target	DA Davidson	Jake Civiello ★★★☆☆ #1428	Neutral	$40.00→ $46.00+15.0%
Sep 10 00:58 UTC	DYN Dyne Therapeutics	◎ Target	Morgan Stanley	Michael Ulz ★☆☆☆☆ #3065	Overweight	$45.00→ $36.00-20.0%
Sep 10 00:58 UTC	DYN Dyne Therapeutics	◎ Target	Robert W. Baird	Brian Skorney ★★☆☆☆ #2525	Outperform	$30.00→ $26.00-13.3%
Sep 10 00:58 UTC	DYN Dyne Therapeutics	◎ Target	Royal Bank Of Canada	Luca Issi ★★★☆☆ #1257	Outperform	$35.00→ $30.00-14.3%
Sep 10 00:58 UTC	DNLM Dunelm Group	◎ Target	JPMorgan Chase & Co.	firm only	Overweight	GBX 1,225→ GBX 1,050-14.3%
Sep 10 00:58 UTC	DNLM Dunelm Group	◎ Target	Deutsche Bank Aktiengesellschaft	firm only	Buy	GBX 1,050→ GBX 1,000-4.8%
Sep 10 00:58 UTC	DEI Douglas Emmett	◎ Target	JPMorgan Chase & Co.	Anthony Paolone ★★★☆☆ #1018	Neutral	$15.00→ $16.00+6.7%
Sep 10 00:58 UTC	CRH CRH	◎ Target	Wells Fargo & Company	Timna Tanners ★★☆☆☆ #2728	Overweight	$132.00→ $107.00-18.9%
Sep 10 00:58 UTC	COIN Coinbase Global	◎ Target	The Goldman Sachs Group	James Yaro ★★☆☆☆ #2427	Buy	$196.00→ $219.00+11.7%
Sep 10 00:58 UTC	CNS Corero Network Security	◎ Target	Canaccord Genuity Group	firm only	Buy	GBX 20→ GBX 21+5.0%
Sep 10 00:58 UTC	CMC Commercial Metals	◎ Target	JPMorgan Chase & Co.	Bennett Moore ★★☆☆☆ #2299	Overweight	$86.00→ $83.00-3.5%
Sep 10 00:58 UTC	CLF Cleveland-Cliffs	◎ Target	JPMorgan Chase & Co.	Bennett Moore ★★☆☆☆ #2299	Neutral	$11.00→ $13.00+18.2%
Sep 10 00:58 UTC	CHYM Chime Financial	◎ Target	Scotiabank	Lance Jessurun not yet tracked	Sec→ r Outperform	$40.00→ $42.00+5.0%
Sep 10 00:58 UTC	CHYM Chime Financial	◎ Target	UBS Group	Timothy Chiodo ★★★★☆ #800	Neutral	$28.00→ $31.00+10.7%
Sep 10 00:58 UTC	CHYM Chime Financial	◎ Target	Piper Sandler	Patrick Moley ★★★☆☆ #1302	Overweight	$35.00→ $40.00+14.3%
Sep 10 00:58 UTC	CHYM Chime Financial	◎ Target	Morgan Stanley	James Faucette ★★★☆☆ #1746	Overweight	$39.00→ $40.00+2.6%
Sep 10 00:58 UTC	CHYM Chime Financial	◎ Target	Barclays	Nik Cremo ★☆☆☆☆ #2925	Overweight	$33.00→ $40.00+21.2%
Sep 10 00:58 UTC	CHYM Chime Financial	◎ Target	Canaccord Genuity Group	Joseph Vafi ★★☆☆☆ #2273	Buy	$45.00→ $50.00+11.1%
Sep 10 00:58 UTC	CHYM Chime Financial	◎ Target	KeyCorp	Alex Markgraff ★★★★☆ #575	Overweight	$33.00→ $40.00+21.2%
Sep 10 00:58 UTC	CCC Computacenter	◎ Target	Berenberg Bank	firm only	Buy	GBX 5,300→ GBX 6,500+22.6%
Sep 10 00:58 UTC	CASY Casey's General Stores	◎ Target	Royal Bank Of Canada	Irene Nattel ★★☆☆☆ #2264	Sec→ r Perform	$913.00→ $910.00-0.3%
Sep 10 00:58 UTC	CASY Casey's General Stores	◎ Target	Wells Fargo & Company	Edward Kelly ★★★☆☆ #1649	Overweight	$960.00→ $750.00-21.9%
Sep 10 00:58 UTC	CAN Canaan	◎ Target	Rosenblatt Securities	Kevin Cassidy ★★★☆☆ #1531	Buy	$1.30→ $0.75-42.3%
Sep 10 00:58 UTC	BXP BXP	◎ Target	Truist Financial	Michael Lewis ★★★☆☆ #1234	Hold	$64.00→ $68.00+6.2%
Sep 10 00:58 UTC	BSX Boston Scientific	◎ Target	BTIG Research	Marie Thibault ★★★☆☆ #1995	Buy	$60.00→ $56.00-6.7%
Sep 10 00:58 UTC	BRZE Braze	◎ Target	Stephens	Brett Huff ★★☆☆☆ #2799	Overweight	$31.00→ $34.00+9.7%
Sep 10 00:58 UTC	BRZE Braze	◎ Target	JPMorgan Chase & Co.	Alexei Gogolev ★★★☆☆ #977	Overweight	$35.00→ $34.00-2.9%
Sep 10 00:58 UTC	BRZE Braze	◎ Target	UBS Group	Taylor McGinnis ★★★★★ #278	Buy	$28.00→ $32.00+14.3%
Sep 10 00:58 UTC	BRZE Braze	◎ Target	Raymond James Financial	Brian Peterson ★★★★☆ #417	Outperform	$27.00→ $33.00+22.2%
Sep 10 00:58 UTC	BRZE Braze	◎ Target	Canaccord Genuity Group	David Hynes ★★★★☆ #645	Buy	$35.00→ $37.00+5.7%
Sep 10 00:58 UTC	BLTE Belite Bio	◎ Target	Mizuho	Graig Suvannavejh ★☆☆☆☆ #2985	Outperform	$220.00→ $234.00+6.4%
Sep 10 00:58 UTC	BBOT BridgeBio Oncology Therapeutics	◎ Target	Canaccord Genuity Group	John Newman ★☆☆☆☆ #2991	Buy	$23.00→ $20.00-13.0%
Sep 10 00:58 UTC	BBOT BridgeBio Oncology Therapeutics	◎ Target	Stifel Nicolaus	Laura Prendergast ★★☆☆☆ #2507	Buy	$23.00→ $15.00-34.8%
Sep 10 00:58 UTC	BBOT BridgeBio Oncology Therapeutics	◎ Target	Raymond James Financial	Sean McCutcheon ★★★★★ #177	Outperform	$24.00→ $22.00-8.3%
Sep 10 00:58 UTC	B Barrick Mining	◎ Target	Sanford C. Bernstein	Bob Brackett ★★★★★ #296	Outperform	$61.00→ $56.50-7.4%
Sep 10 00:58 UTC	APH Amphenol	◎ Target	TD Cowen	Joseph Giordano ★★★☆☆ #1750	Hold	$175.00→ $90.00-48.6%
Sep 10 00:58 UTC	APD Air Products and Chemicals	◎ Target	Argus	Alexandra Yates ★★★★★ #277	Buy	$316.00→ $329.00+4.1%
Sep 10 00:58 UTC	ADBE Adobe	◎ Target	Stifel Nicolaus	Parker Lane not yet tracked	Hold	$200.00→ $225.00+12.5%
Sep 10 00:58 UTC	ABM ABM Industries	◎ Target	UBS Group	Joshua Chan ★★★☆☆ #1300	Neutral	$45.00→ $51.50+14.4%
Sep 10 00:58 UTC	ABM ABM Industries	◎ Target	Robert W. Baird	Andrew Wittmann ★★★★☆ #340	Neutral	$48.00→ $53.00+10.4%
Sep 10 00:58 UTC	VMC Vulcan Materials	↓ Downgrade	Wells Fargo & Company	Timna Tanners ★★☆☆☆ #2728	Equal Weight→ Underweight	$305.00→ $254.00-16.7%
Sep 10 00:58 UTC	VMC Vulcan Materials	↓ Downgrade	Citigroup	Anthony Pettinari ★★★☆☆ #1141	Buy→ Cautious
Sep 10 00:58 UTC	TMO Thermo Fisher Scientific	↓ Downgrade	BMO Capital Markets	firm only	Market Perform

🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.

A free account unlocks the full daily feed.

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.

Analyst Rating Changes — Upgrades, Downgrades & Price Targets

Latest Rating Changes

Frequently Asked Questions

Welcome to 13Foresight!